Recent insider trading activity from Fink Jeffrey Arvin, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 4, 2025 | Lipocine Inc. | $LPCN | Fink Jeffrey Arvin | Director | A | Common Stock (Right to Buy) | 1764 | $3.20 | 11,526.0000 | 5,350,356 | 18.07% | 0.03% |
| June 5, 2024 | Lipocine Inc. | $LPCN | Fink Jeffrey Arvin | Director | A | Common Stock (Right to Buy) | 1764 | $7.05 | 10,938.0000 | 0 | 19.23% | 0.00% |